TABLE 6.

Running clinical trials for validation of Ivermectin (https://clinicaltrials.gov/ct2/results).

Sl. No.	Title	NCT No.	Therapeutic Dose	Phase	Location
1	Validation of Ivermectin and Nitazoxanide efficacy	NCT04351347	Not specified	2,3	Egypt
2	Validating polytherapy of Nitazoxanide and Ivermectin	NCT04360356	Not specified	2,3	Egypt
3	Combinatorial therapy of HCQ and Azithromycin along with Ivermectin	NCT04343092	Ivermectin (0.2 mg/kg, 2 tablets of 6 mg per week)	1	Iraq
4	Clinical trials for promoting safety and efficacy of Ivermectin or Endocrine therapy	NCT04374279	Ivermectin (600 µg/kg), once/day for 3 days	2	U.S.
5	Evaluation of Ivermectin along with standard regimen	NCT04373824	Ivermectin (200–400 mcg/kg) for first day and the second day was given with standard care	Not applicable	India